Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Ugandan Pharmaceutical Plant Wins WHO Approval for ARV Manufacturing

From Henry J. Kaiser Family Foundation

March 11, 2010

The WHO recently approved the manufacturing of antiretrovirals (ARVs) in Kampala, Uganda, by the pharmaceutical company Quality Chemicals Industries, New Vision/allAfrica.com reports. The plant is the first to win WHO approval outside of South Africa and is expected to "reduce the monthly cost of ARVs from sh30,000 to sh16,000 (29 to 14 USD)," according to the news service. The company "intends to export to neighbouring Kenya, Burundi, Rwanda, Tanzania, the Democratic Republic of Congo and Sudan," New Vision/allAfrica.com writes (Nabusoba, 3/10).

Back to other news for March 2010


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More on HIV/AIDS Treatment in Uganda

Tools
 

Advertisement